Mirae Asset Global Investments
ATRA icon

Mirae Asset Global Investments’s Atara Biotherapeutics ATRA Stock Holding History

Mirae Asset Global Investments’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-951
Closed -$68.9K – 2607
2023
Q1 		$68.9K Sell
951
-599
-39% -$58.1K ﹤0.01% 2495
2022
Q4 		$127K Buy
1,550
+2
+0.1% +$208 ﹤0.01% 2413
2022
Q3 		$146K Buy
1,548
+468
+43% +$52.6K ﹤0.01% 2432
2022
Q2 		$211K Buy
+1,080
New +$176K ﹤0.01% 2131

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global Investments's ATRA Position: Q2 2023 in Review

Mirae Asset Global Investments sold out of Atara Biotherapeutics (ATRA) in Q2 2023, closing a stake of 951 shares — an estimated $68.9K sold.

Mirae Asset Global Investments first reported a position in ATRA in Q2 2022 and held it in 4 quarters. The position peaked at $211K in Q2 2022. 118 funds tracked by Wall St. Rank hold ATRA as of Q2 2023.

  • Mirae Asset Global Investments reported no remaining Atara Biotherapeutics position as of Q2 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 951 Atara Biotherapeutics shares in Q2 2023, an estimated $68.9K.
  • Mirae Asset Global Investments first reported a position in Atara Biotherapeutics in Q2 2022 and held it in 4 quarters.
  • Mirae Asset Global Investments's Atara Biotherapeutics position peaked at $211K in Q2 2022.
  • 118 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2023.

Based on Mirae Asset Global Investments's 13F filing for Q2 2023, filed 10 Aug 2023.